Different effects of the different natural CC chemokine receptor 2b ligands on β-arrestin recruitment, Gαi signaling, and receptor internalization

Molecular Pharmacology

Volumn 79, Issue 3, 2011, Pages 488-498

  Berchiche, Yamina A ^a,b   Gravel, Sté Phanie ^a,b   Pelletier, Marie Eve ^a,b   St Onge, Geneviève ^a,b   Heveker, Nikolaus ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN; CHEMOKINE RECEPTOR CCR2; EOTAXIN; EOTAXIN 2; EOTAXIN 3; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 4; PERTUSSIS TOXIN;

ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; HUMAN; HUMAN CELL; INTERNALIZATION; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ARRESTINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCYTOSIS; FLOW CYTOMETRY; GTP-BINDING PROTEIN ALPHA SUBUNITS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HEK293 CELLS; HUMANS; LIGANDS; PERTUSSIS TOXIN; PROTEIN BINDING; RADIOLIGAND ASSAY; RECEPTORS, CCR2; SIGNAL TRANSDUCTION;

EID: 79951970155     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.110.068486     Document Type: Article

References (40)

1. Amoura Z, Combadiere C, Faure S, Parizot C, Miyara M, Raphaël D, Ghillani P, Debre P, Piette JC, and Gorochov G (2003) Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares. Arthritis Rheum 48:3487-3496. (Pubitemid 37531914)
2. Aragay AM, Mellado M, Frade JM, Martin AM, Jimenez-Sainz MC, Martinez-A C, and Mayor F Jr (1998) Monocyte chemoattractant protein-1-induced CCR2B receptor desensitization mediated by the G protein-coupled receptor kinase 2. Proc Natl Acad Sci USA 95:2985-2990. (Pubitemid 28135841)
3. Berchiche YA, Chow KY, Lagane B, Leduc M, Percherancier Y, Fujii N, Tamamura H, Bachelerie F, and Heveker N (2007) Direct assessment of CXCR4 mutant conformations reveals complex link between receptor structure and G(alpha)(i) activation. J Biol Chem 282:5111-5115. (Pubitemid 47093712)
4. Berkhout TA, Sarau HM, Moores K, White JR, Elshourbagy N, Appelbaum E, Reape RJ, Brawner M, Makwana J, Foley JJ, et al. (1997) Cloning, in vitro expression, and functional characterization of a novel human CC chemokine of the monocyte chemotactic protein (MCP) family (MCP-4) that binds and signals through the CC chemokine receptor 2B. J Biol Chem 272:16404-16413. (Pubitemid 27276466)
5. Byers MA, Calloway PA, Shannon L, Cunningham HD, Smith S, Li F, Fassold BC, and Vines CM (2008) Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21. J Immunol 181:4723-4732.
6. Cheung R, Malik M, Ravyn V, Tomkowicz B, Ptasznik A, and Collman RG (2009) An arrestin-dependent multi-kinase signaling complex mediates MIP-1beta/CCL4 signaling and chemotaxis of primary human macrophages. J Leukoc Biol 86:833-845.
7. Combadiere C, Ahuja SK, Van Damme J, Tiffany HL, Gao JL, and Murphy PM (1995) Monocyte chemoattractant protein-3 is a functional ligand for CC chemokine receptors 1 and 2B. J Biol Chem 270:29671-29675. (Pubitemid 26001630)
8. D'Ambrosio D, Albanesi C, Lang R, Girolomoni G, Sinigaglia F, and Laudanna C (2002) Quantitative differences in chemokine receptor engagement generate diversity in integrin-dependent lymphocyte adhesion. J Immunol 169:2303-2312. (Pubitemid 34920970)
9. Dupré DJ, Robitaille M, Ethier N, Villeneuve LR, Mamarbachi AM, and Hébert TE (2006) Seven transmembrane receptor core signaling complexes are assembled prior to plasma membrane trafficking. J Biol Chem 281:34561-34573.
10. Ehlert FJ (2005) Analysis of allosterism in functional assays. J Pharmacol Exp Ther 315:740-754.
11. Ehlert FJ (2008) On the analysis of ligand-directed signaling at G protein-coupled receptors. Naunyn Schmiedebergs Arch Pharmacol 377:549-577.
12. Galés C, Rebois RV, Hogue M, Trieu P, Breit A, Hébert TE, and Bouvier M (2005) Real-time monitoring of receptor and G-protein interactions in living cells. Nat Methods 2:177-184. (Pubitemid 41122124)
13. Galés C, Van Durm JJ, Schaak S, Pontier S, Percherancier Y, Audet M, Paris H, and Bouvier M (2006) Probing the activation-promoted structural rearrangements in preassembled receptor-G protein complexes. Nat Struct Mol Biol 13:778-786. (Pubitemid 44338771)
14. García Lopez MA, Aguado Martínez A, Lamaze C, Martínez-A C, and Fischer T (2009) Inhibition of dynamin prevents CCL2-mediated endocytosis of CCR2 and activation of ERK1/2. Cell Signal 21:1748-1757.
15. Gong X, Gong W, Kuhns DB, Ben-Baruch A, Howard OM, and Wang JM (1997) Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors. J Biol Chem 272:11682-11685. (Pubitemid 27202727)
16. Hanna J, Mussaffi H, Steuer G, Hanna S, Deeb M, Blau H, Arnon TI, Weizman N, and Mandelboim O (2005) Functional aberrant expression of CCR2 receptor on chronically activated NK cells in patients with TAP-2 deficiency. Blood 106:3465-3473. (Pubitemid 41609182)
17. Jiang LI, Collins J, Davis R, Lin KM, DeCamp D, Roach T, Hsueh R, Rebres RA, Ross EM, Taussig R, et al. (2007) Use of a cAMP BRET sensor to characterize a novel regulation of cAMP by the sphingosine 1-phosphate/G13 pathway. J Biol Chem 282:10576-10584. (Pubitemid 47093456)
18. Kalatskaya I, Berchiche YA, Gravel S, Limberg BJ, Rosenbaum JS, and Heveker N (2009) AMD3100 is a CXCR7 ligand with allosteric agonist properties. Mol Pharmacol 75:1240-1247.
19. Kenakin T (2004) G-protein coupled receptors as allosteric machines. Receptors Channels 10:51-60.
20. Kenakin T (2007) Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors. Trends Pharmacol Sci 28:407-415.
21. Kendall RT and Luttrell LM (2009) Diversity in arrestin function. Cell Mol Life Sci 66:2953-2973.
22. Kobilka BK and Deupi X (2007) Conformational complexity of G-protein-coupled receptors. Trends Pharmacol Sci 28:397-406. (Pubitemid 47087966)
23. Kohout TA, Nicholas SL, Perry SJ, Reinhart G, Junger S, and Struthers RS (2004) Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7. J Biol Chem 279:23214-23222. (Pubitemid 38685628)
24. Leach K, Charlton SJ, and Strange PG (2007) Analysis of second messenger pathways stimulated by different chemokines acting at the chemokine receptor CCR5. Biochem Pharmacol 74:881-890. (Pubitemid 47212077)
25. Leduc M, Breton B, Galés C, Le Gouill C, Bouvier M, Chemtob S, and Heveker N (2009) Functional selectivity of natural and synthetic prostaglandin EP4 receptor ligands. J Pharmacol Exp Ther 331:297-307.
26. Martinelli R, Sabroe I, LaRosa G, Williams TJ, and Pease JE (2001) The CC chemokine eotaxin (CCL11) is a partial agonist of CC chemokine receptor 2b. J Biol Chem 276:42957-42964.
27. Mine S, Okada Y, Tanikawa T, Kawahara C, Tabata T, and Tanaka Y (2006) Increased expression levels of monocyte CCR2 and monocyte chemoattractant protein-1 in patients with diabetes mellitus. Biochem Biophys Res Commun 344:780-785.
28. Murphy PM, Baggiolini M, Charo IF, Hébert CA, Horuk R, Matsushima K, Miller LH, Oppenheim JJ, and Power CA (2000) International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52:145-176.
29. Myers SJ, Wong LM, and Charo IF (1995) Signal transduction and ligand specificity of the human monocyte chemoattractant protein-1 receptor in transfected embryonic kidney cells. J Biol Chem 270:5786-5792.
30. Nikolaev VO, Hoffmann C, Bünemann M, Lohse MJ, and Vilardaga JP (2006) Molecular basis of partial agonism at the neurotransmitter alpha2A-adrenergic receptor and Gi-protein heterotrimer. J Biol Chem 281:24506-24511. (Pubitemid 44274225)
31. O'Boyle G, Brain JG, Kirby JA, and Ali S (2007) Chemokine-mediated inflammation: Identification of a possible regulatory role for CCR2. Mol Immunol 44:1944-1953.
32. Ogilvie P, Bardi G, Clark-Lewis I, Baggiolini M, and Uguccioni M (2001) Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5. Blood 97:1920-1924. (Pubitemid 32239067)
33. Ogilvie P, Paoletti S, Clark-Lewis I, and Uguccioni M (2003) Eotaxin-3 is a natural antagonist for CCR2 and exerts a repulsive effect on human monocytes. Blood 102:789-794. (Pubitemid 36917764)
34. Ogilvie P, Thelen S, Moepps B, Gierschik P, da Silva Campos AC, Baggiolini M, and Thelen M (2004) Unusual chemokine receptor antagonism involving a mitogen-activated protein kinase pathway. J Immunol 172:6715-6722. (Pubitemid 38669108)
35. Oppermann M, Mack M, Proudfoot AE, and Olbrich H (1999) Differential effects of CC chemokines on CC chemokine receptor 5 (CCR5) phosphorylation and identification of phosphorylation sites on the CCR5 carboxyl terminus. J Biol Chem 274:8875-8885. (Pubitemid 29164688)
36. Parody TR and Stone MJ (2004) High level expression, activation, and antagonism of CC chemokine receptors CCR2 and CCR3 in Chinese hamster ovary cells. Cytokine 27:38-46. (Pubitemid 38780935)
37. Percherancier Y, Berchiche YA, Slight I, Volkmer-Engert R, Tamamura H, Fujii N, Bouvier M, and Heveker N (2005) Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers. J Biol Chem 280:9895-9903. (Pubitemid 40395837)
38. Rajagopal S, Kim J, Ahn S, Craig S, Lam CM, Gerard NP, Gerard C, and Lefkowitz RJ (2010) Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7. Proc Natl Acad Sci USA 107:628-632.
39. Sozzani S, Zhou D, Locati M, Rieppi M, Proost P, Magazin M, Vita N, van Damme J, and Mantovani A (1994) Receptors and transduction pathways for monocyte chemotactic protein-2 and monocyte chemotactic protein-3. Similarities and differences with MCP-1. J Immunol 152:3615-3622. (Pubitemid 24098059)
40. Springael JY, Le Minh PN, Urizar E, Costagliola S, Vassart G, and Parmentier M (2006) Allosteric modulation of binding properties between units of chemokine receptor homo- and hetero-oligomers. Mol Pharmacol 69:1652-1661.